Chitosan/hydroxyapatite nanocomposite scaffolds to modulate osteogenic and inflammatory response

Considerable attention has been given to the use of chitosan (CS)‐based materials reinforced with inorganic bioactive signals such as hydroxyapatite (HA) to treat bone defects and tissue loss. It is well known that CS/HA based materials possess minimal foreign body reactions, good biocompatibility,...

Descripción completa

Detalles Bibliográficos
Autores principales: Soriente, Alessandra, Fasolino, Ines, Gomez‐Sánchez, Alejandro, Prokhorov, Evgen, Buonocore, Giovanna Giuliana, Luna‐Barcenas, Gabriel, Ambrosio, Luigi, Raucci, Maria Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291049/
https://www.ncbi.nlm.nih.gov/pubmed/34331513
http://dx.doi.org/10.1002/jbm.a.37283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291049/
https://www.ncbi.nlm.nih.gov/pubmed/34331513
http://dx.doi.org/10.1002/jbm.a.37283

Ejemplares similares